MEDICINAL CHEMISTRY AND DRUG DISCOVERY BIOLOGY
STRATEGY MEETING EAST COAST USA 2025
ENTER YOUR DETAILS BELOW AND WE'LL SEND YOU MORE INFORMATION
DOWNLOAD THE REPORT
Proventa's recent survey of Drug Discovery Biology and Medicinal Chemistry leaders highlights AI/ML, Hit-to-Lead Optimization, and Target Validation as top investment priorities. Pressing challenges such as limited funding, efficiency-driven timelines, and fragmented data infrastructure continue to shape discovery workflows. Investment decisions are increasingly driven by the need for accelerated development, scientifically validated targets, and alignment with broader growth strategies. Understanding these shifts is essential to driving innovation and maintaining competitive advantage across the modern drug discovery value chain.
Hyatt Regency Princeton
May 14th
